T‐box 3 negatively regulates osteoblast differentiation by inhibiting expression of osterix and runx2
Authors:
- 29 December 2008
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 106 (3) , 482-490
Abstract
T‐box (Tbx)3, a known transcriptional repressor, is a member of a family of transcription factors, which contain a highly homologous DNA binding domain known as the Tbx domain. Based on the knowledge that mutation of the Tbx3 gene results in limb malformation, Tbx3 regulates osteoblast proliferation and its expression increases during osteoblast differentiation, we predicted that Tbx3 is an important regulator of osteoblast cell functions. In this study, we evaluated the consequence of transgenic overexpression of Tbx3 on osteoblast differentiation. Retroviral overexpression increased Tbx3 expression >100‐fold at the mRNA and protein level. Overexpression of Tbx3 blocked mineralized nodule formation (28 ± 8 vs. 7 ± 1%) in MC3T3‐E1 cells. In support of these data, alkaline phosphatase (ALP) activity was reduced 33–70% (P < 0.05) in both MC3T3‐E1 cells and primary calvaria osteoblasts overexpressing Tbx3. In contrast, Tbx3 overexpression did not alter ALP activity in bone marrow stromal cells. Tbx3 overexpression blocked the increase in expression of key osteoblast marker genes, ALP, bone sialoprotein, and osteocalcin that occurs during normal osteoblast differentiation, but had little or no effect on expression of proliferation genes p53 and Myc. In addition, Tbx3 overexpression abolished increased osterix and runx2 expression observed during normal osteoblast differentiation, but the change in Msx1 and Msx2 expression over time was similar between control and Tbx3 overexpressing cells. Interestingly, osterix and runx2, but not Msx1 and Msx2, contain Tbx binding site in the regulatory region. Based on these data and our previous findings, we conclude that Tbx3 promotes proliferation and suppresses differentiation of osteoblasts and may be involved in regulating expression of key transcription factors involved in osteoblast differentiation. J. Cell. Biochem. 106: 482–490, 2009.Keywords
This publication has 43 references indexed in Scilit:
- Msx1 and Msx2 are functional interacting partners of T-box factors in the regulation of Connexin43Cardiovascular Research, 2008
- Disruption of insulin-like growth factor-I expression in type IIαI collagen-expressing cells reduces bone length and width in micePhysiological Genomics, 2007
- TBX3, the gene mutated in ulnar-mammary syndrome, promotes growth of mammary epithelial cells via repression of p19ARF, independently of p53Cell and tissue research, 2007
- Tbx5 and Tbx4 transcription factors interact with a new chicken PDZ-LIM protein in limb and heart developmentDevelopmental Biology, 2004
- GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5Nature, 2003
- Stage specific inhibition of osteoblast lineage differentiation by FGF2 and nogginJournal of Cellular Biochemistry, 2003
- Functional Analysis of TBX5 Missense Mutations Associated with Holt-Oram SyndromeJournal of Biological Chemistry, 2003
- The T-box Repressors TBX2 and TBX3Specifically Regulate the Tumor Suppressor Genep14 via a Variant T-site in the InitiatorJournal of Biological Chemistry, 2002
- Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiationOncogene, 2002
- Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndromeNature Genetics, 1997